You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (34) |
Back to Search
Clinical and molecular review of Congenital Adrenal Hyperplasia from a laboratory point of view
- At: Virtual 2020 (2020)
- Type: Poster
- Poster code: POS-CBS-008
- By: RODRíGUEZ, Argeme (Ramón y Cajal University Hospital, Madrid, Clinical Biochemistry Service, Spain)
- Co-author(s): Argeme Rodríguez: Clinical Biochemistry Service, Ramón y Cajal University Hospital, Madrid, Spain
Ana García: Clinical Biochemistry Service, Ramón y Cajal University Hospital, Madrid, Spain
Marta Rosillo: Clinical Biochemistry Service, Ramón y Cajal University Hospital, Madrid, Spain
Lucía Jiménez: Clinical Biochemistry Service, Ramón y Cajal University Hospital, Madrid, Spain
Marta García-Collía: Clinical Laboratory Committee, General Council of Pharmaceutical Colleges, Madrid, Spain
Ignacio Arribas: Clinical Biochemistry Service, Ramón y Cajal University Hospital, Madrid, Spain - Abstract:
Background
Congenital adrenal hyperplasia (CAH) is a disorder in steroidogenesis caused by an enzymatic deficiency, such as 21hydroxylase due to mutations in the CYP21A2 gene.This deficiency produces a decrease in mineralocorticoids and glucocorticoids, and an accumulation of 17 hydroxyprogesterone (17-OHP) and androgens. But clinical forms can
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026